Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)

Authors :: Thierry Jahan
S. Blakemore
Tom Wei-Wu Chen
Robin L. Jones
Mrinal M. Gounder
Antoine Italiano
Patrick Schöffski
Abha A. Gupta
Elizabeth T. Loggers
Mark Agulnik
Maria Roche
Rashmi Chugh
Gregory M. Cote
S. Daigle
Steven Attia
Silvia Stacchiotti
G. D.D. Demetri
A. Clawson
B.A. Van Tine
Victor M. Villalobos
Source :: Annals of Oncology. 29:viii670
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Pathology
medicine.medical_specialty
Tazemetostat
business.industry
Epithelioid sarcoma
Phases of clinical research
Hematology
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
medicine
business

Full Text Access

Tools